Abstract: The present invention relates to compounds of the Formula or a pharmaceutically acceptable salt, solvate, hydrate or formulation thereof. These compounds can be used for the inhibition of Factor Xa and for the treatment and/or prevention of diseases that are mediated by Factor Xa activity.
Type:
Grant
Filed:
February 22, 2002
Date of Patent:
August 14, 2007
Assignee:
Morphochem
Inventors:
Sven Nerdinger, Thilo Fuchs, Katrin Illgen, Robert Eckl